Valve-Sparing Root Replacement Versus Bio-Bentall: Inverse Propensity Weighting of 796 Patients

Casidhe-Nicole Bethancourt1, David Blitzer2, Tsuyoshi Yamabe3

  • 1Columbia University Vagelos College of Physicians and Surgeons, New York, New York; Division of Cardiothoracic and Vascular Surgery, NewYork-Presbyterian Hospital, Columbia University Irving Medical Center, New York, New York.

Insights

Valve-sparing root replacement (VSRR) and bioprosthetic Bentall (bio-Bentall) demonstrate comparable 10-year survival and aortic valve reintervention rates. Durable solutions for young patients with bicuspid aortic valves undergoing these procedures remain a challenge.

Area of Science:

  • Cardiovascular Surgery
  • Thoracic Surgery
  • Aortic Surgery

Background:

  • Aortic root aneurysm necessitates surgical intervention, with valve-sparing root replacement (VSRR) and bioprosthetic Bentall (bio-Bentall) being common approaches.
  • Comparing long-term outcomes of VSRR versus bio-Bentall is crucial for surgical decision-making in aortic root pathology.

Purpose of the Study:

  • To compare the 10-year survival and freedom from aortic valve reintervention between VSRR and bio-Bentall procedures.
  • To identify factors associated with aortic valve reintervention after aortic root surgery.

Main Methods:

  • A retrospective review of 796 patients undergoing elective VSRR or bio-Bentall for aortic root aneurysm.
  • Inverse probability of treatment weighting (IPTW) was used to balance clinical variables between the VSRR and bio-Bentall groups.
  • A Fine and Gray competing risk regression model analyzed factors associated with aortic valve reintervention.

Main Results:

  • After IPTW, 10-year survival was similar between VSRR (87.0%) and bio-Bentall (92.7%, P=0.780).
  • Cumulative incidence of aortic valve reintervention at 10 years was comparable: 5.9% for VSRR and 10.6% for bio-Bentall (P=0.798).
  • Age, body surface area, and bicuspid aortic valve were independently associated with aortic valve reintervention.

Conclusions:

  • Both VSRR and bio-Bentall offer excellent and similar 10-year survival and freedom from aortic valve reintervention.
  • A significant challenge persists in finding durable valve solutions for younger patients, particularly those with bicuspid aortic valves.
Abstract

Related Concept Videos